• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者纵向症状变化及其与居家时间的关联:一项观察性数字化表型研究。

Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study.

机构信息

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA; Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Schizophr Res. 2022 May;243:64-69. doi: 10.1016/j.schres.2022.02.031. Epub 2022 Mar 1.

DOI:10.1016/j.schres.2022.02.031
PMID:35245703
Abstract

BACKGROUND

Smartphone assessments and sensors offer the ability to easily assess symptoms across environments in a naturalistic and longitudinal manner. However, the value of this new data to make inferences about personal vs population health and the role of environment in moderating symptoms in schizophrenia has not been fully explored in a scalable and reproducible manner.

METHODS

Eighty-six adults with a diagnosis of schizophrenia were recruited from the Greater Boston Area between August 2019 and May 2021. Using the open-source mindLAMP app in an observational manner, smartphone surveys and sensors (GPS, accelerometer, screen on/off and call and text logs) were collected for up to six months.

RESULTS

Sixty-three participants were analyzed, who had at least completed one survey in the app. App-based self-reported symptom surveys were highly correlated with scores on gold standard clinical assessments (r = 0.80, p = 10 for mood and r = 0.78, p = 10 for anxiety). For these app-based assessments, inter-individual differences account for a larger proportion of the correlations in longitudinal symptoms as compared to intra-individual differences. Mood, sleep, and psychosis symptoms reported on app surveys were more severe when taken at home as determined by the smartphone's GPS sensor.

DISCUSSION

The intra-individual symptom correlations and the stratification of symptoms by home-time highlight the utility of digital phenotyping methods as a diagnostic tool, as well as the potential for personalized psychiatric treatment building on this data.

摘要

背景

智能手机评估和传感器能够以自然和纵向的方式轻松评估跨环境的症状。然而,这种新数据对于推断个人与人群健康以及环境在调节精神分裂症症状方面的作用的价值,尚未以可扩展和可重复的方式得到充分探索。

方法

2019 年 8 月至 2021 年 5 月期间,从大波士顿地区招募了 86 名被诊断为精神分裂症的成年人。以观察的方式使用开源的 mindLAMP 应用程序,收集智能手机调查和传感器(GPS、加速度计、屏幕开/关以及通话和短信记录)长达六个月。

结果

对 63 名参与者进行了分析,他们至少在应用程序中完成了一次调查。基于应用程序的自我报告症状调查与黄金标准临床评估的分数高度相关(r = 0.80,p = 10 用于情绪,r = 0.78,p = 10 用于焦虑)。对于这些基于应用程序的评估,个体间差异在纵向症状中的相关性中占比更大,而个体内差异则占比较小。智能手机 GPS 传感器确定的,在家中进行的基于应用程序的调查中报告的情绪、睡眠和精神病症状更为严重。

讨论

个体内症状相关性以及在家时间对症状的分层突出了数字表型方法作为诊断工具的效用,以及基于此数据构建个性化精神科治疗的潜力。

相似文献

1
Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study.精神分裂症患者纵向症状变化及其与居家时间的关联:一项观察性数字化表型研究。
Schizophr Res. 2022 May;243:64-69. doi: 10.1016/j.schres.2022.02.031. Epub 2022 Mar 1.
2
Measuring Environmental and Behavioral Drivers of Chronic Diseases Using Smartphone-Based Digital Phenotyping: Intensive Longitudinal Observational mHealth Substudy Embedded in 2 Prospective Cohorts of Adults.使用基于智能手机的数字表型测量慢性病的环境和行为驱动因素:嵌入在 2 项前瞻性成人队列中的密集纵向观察性移动健康子研究。
JMIR Public Health Surveill. 2024 Oct 11;10:e55170. doi: 10.2196/55170.
3
Digital phenotyping data and anomaly detection methods to assess changes in mood and anxiety symptoms across a transdiagnostic clinical sample.用于评估跨诊断临床样本中情绪和焦虑症状变化的数字表型数据及异常检测方法。
Acta Psychiatr Scand. 2025 Mar;151(3):388-400. doi: 10.1111/acps.13712. Epub 2024 May 28.
4
Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study.智能手机数字表型分析、调查及认知评估在全球精神卫生中的应用:一项国际首发精神病研究的初始数据及临床相关性
Digit Health. 2022 Nov 8;8:20552076221133758. doi: 10.1177/20552076221133758. eCollection 2022 Jan-Dec.
5
Findings From a Trial of the Smartphone and OnLine Usage-based eValuation for Depression (SOLVD) Application: What Do Apps Really Tell Us About Patients with Depression? Concordance Between App-Generated Data and Standard Psychiatric Questionnaires for Depression and Anxiety.基于智能手机和在线使用情况的抑郁症评估(SOLVD)应用程序试验的结果:应用程序究竟能告诉我们关于抑郁症患者的哪些信息?应用程序生成的数据与抑郁症和焦虑症标准精神科问卷之间的一致性。
J Psychiatr Pract. 2019 Sep;25(5):365-373. doi: 10.1097/PRA.0000000000000420.
6
Digital Phenotyping Data to Predict Symptom Improvement and Mental Health App Personalization in College Students: Prospective Validation of a Predictive Model.数字表型数据预测大学生症状改善和心理健康应用个性化:预测模型的前瞻性验证。
J Med Internet Res. 2023 Feb 9;25:e39258. doi: 10.2196/39258.
7
Exploring the Neuropsychiatric Sequalae of Perceived COVID-19 Exposure in College Students: A Pilot Digital Phenotyping Study.探索大学生中感知到的新冠病毒暴露后的神经精神后遗症:一项初步数字表型研究
Front Psychiatry. 2022 Jan 10;12:788926. doi: 10.3389/fpsyt.2021.788926. eCollection 2021.
8
Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.使用应用程序(elevateMS)在真实世界中评估基于智能手机传感器评估对多发性硬化症患者的效用:观察性、前瞻性试点数字健康研究。
JMIR Mhealth Uhealth. 2020 Oct 27;8(10):e22108. doi: 10.2196/22108.
9
A comparison of passive and active estimates of sleep in a cohort with schizophrenia.精神分裂症队列中睡眠的被动与主动评估比较。
NPJ Schizophr. 2017 Oct 16;3(1):37. doi: 10.1038/s41537-017-0038-0.
10
Feasibility and correlations of smartphone meta-data toward dynamic understanding of depression and suicide risk in schizophrenia.智能手机元数据对精神分裂症患者抑郁和自杀风险的动态理解的可行性及相关性。
Int J Methods Psychiatr Res. 2020 Jun;29(2):e1825. doi: 10.1002/mpr.1825. Epub 2020 Apr 25.

引用本文的文献

1
Digital measures of activity and motivation impact depression and anxiety in the real world.在现实世界中,活动和动机的数字测量会影响抑郁和焦虑。
NPJ Digit Med. 2025 May 10;8(1):268. doi: 10.1038/s41746-025-01669-0.
2
Forecasting mental states in schizophrenia using digital phenotyping data.利用数字表型数据预测精神分裂症的心理状态。
PLOS Digit Health. 2025 Feb 7;4(2):e0000734. doi: 10.1371/journal.pdig.0000734. eCollection 2025 Feb.
3
Biomarker Methodologies: A NIMH Perspective.生物标志物方法学:NIMH 的观点。
Adv Neurobiol. 2024;40:3-44. doi: 10.1007/978-3-031-69491-2_1.
4
Digital phenotyping correlates of mobile cognitive measures in schizophrenia: A multisite global mental health feasibility trial.精神分裂症中移动认知测量的数字表型相关性:一项多中心全球心理健康可行性试验。
PLOS Digit Health. 2024 Jun 28;3(6):e0000526. doi: 10.1371/journal.pdig.0000526. eCollection 2024 Jun.
5
Digital Phenotyping for Monitoring Mental Disorders: Systematic Review.数字表型监测精神障碍:系统评价。
J Med Internet Res. 2023 Dec 13;25:e46778. doi: 10.2196/46778.
6
Technology use and attitudes towards digital mental health in people with severe mental health problems: a survey study in China.重度精神健康问题患者的技术使用情况及对数字心理健康的态度:一项中国的调查研究
Front Psychiatry. 2023 Nov 22;14:1261795. doi: 10.3389/fpsyt.2023.1261795. eCollection 2023.
7
Increasing the value of digital phenotyping through reducing missingness: a retrospective review and analysis of prior studies.通过减少缺失值来提高数字表型的价值:对先前研究的回顾性审查和分析。
BMJ Ment Health. 2023 Feb;26(1). doi: 10.1136/bmjment-2023-300718.
8
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.精神药理学的未来:对正在进行的2/3期试验以及旨在降低新型药物试验项目风险的一些当前趋势的批判性评估。
World Psychiatry. 2023 Feb;22(1):48-74. doi: 10.1002/wps.21056.
9
Accessibility and availability of smartphone apps for schizophrenia.用于精神分裂症的智能手机应用程序的可及性和可用性。
Schizophrenia (Heidelb). 2022 Nov 16;8(1):98. doi: 10.1038/s41537-022-00313-0.
10
Regulatory considerations to keep pace with innovation in digital health products.跟上数字健康产品创新步伐的监管考量。
NPJ Digit Med. 2022 Aug 19;5(1):121. doi: 10.1038/s41746-022-00668-9.